Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects.

MLA

van Karnebeek, Clara D., et al. “Secondary Biogenic Amine Deficiencies: Genetic Etiology, Therapeutic Interventions, and Clinical Effects.” Neurogenetics, vol. 22, no. 4, Oct. 2021, pp. 251–62. EBSCOhost, https://doi.org/10.1007/s10048-021-00652-7.

APA

van Karnebeek, C. D., Blydt-Hansen, I., Matthews, A. M., Avramovic, V., Price, M., Drogemoller, B., Shyr, C., Lee, J., Mwenifumbo, J., Ghani, A., Stockler, S., Friedman, J. M., Lehman, A., Ross, C. J., Wasserman, W. W., Tarailo-Graovac, M., & Horvath, G. A. (2021). Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects. Neurogenetics, 22(4), 251–262. https://doi.org/10.1007/s10048-021-00652-7

Chicago

van Karnebeek, Clara D., Ingrid Blydt-Hansen, Allison M. Matthews, Vladimir Avramovic, Magda Price, Britt Drogemoller, Casper Shyr, et al. 2021. “Secondary Biogenic Amine Deficiencies: Genetic Etiology, Therapeutic Interventions, and Clinical Effects.” Neurogenetics 22 (4): 251–62. doi:10.1007/s10048-021-00652-7.